The global manufacturing execution system in life sciences market accounted for USD 2.78 billion in 2023 and is expected to reach at USD 9.91 billion by 2034 with a CAGR of 12.25% during the forecast period 2024-2034. Surge in regulatory adherence, growing demand for real-time data & analytics, expansion of the biopharmaceutical industry, rapid technological progress, rising adoption of digitization, heightened intricacy in pharmaceutical & biotechnology production, escalating necessity for accurate data handling, increased interest in personalized medicine, growing demand for cutting-edge treatments, surge in merger & acquisition (M&A) undertakings among key market players, and increase in the introduction of advanced manufacturing execution systems in life sciences are some of the key factors boosting the market growth.
Increase in the introduction of advanced manufacturing execution systems in life sciences is predicted to boost the market growth during the forecast period. The integration of Manufacturing Execution System (MES) is becoming increasingly pivotal in the life science sector, contributing to enhancements in efficiency, compliance, and innovation throughout production operations. Industries within life sciences, such as pharmaceuticals and biotechnology, demand a refined strategy for managing manufacturing processes. MES offers comprehensive and data-oriented solutions that play a crucial role in fulfilling and surpassing regulatory standards, mitigating risks, and maintaining product quality. For instance, in January 2022, POMS Corporation introduced new MES Dashboards and Batch Records tailored for drug manufacturers operating in the pharmaceutical, biotechnology, and cell and gene sectors. This unveiling is anticipated to provide notable advantages to manufacturers within these industries.
By solution, software was the highest revenue-grossing segment in the global manufacturing execution system in life sciences market in 2023 owing to the growing focus on ensuring data integrity, traceability, & regulatory adherence within the life sciences sector, rising need for comprehensive visibility throughout the entire manufacturing lifecycle, uptick in research & development initiatives, life sciences companies are increasingly investing in Manufacturing Execution System (MES) solutions that provide seamless data integration and analytics capabilities, and rising collaborations among market participants. For instance, in September 2023, Korber and Endeavor have joined forces to streamline the integration of Werum PAS-X MES with SAP's ERP platform. This collaboration is designed to offer a seamless solution to businesses utilizing both software platforms for their operations. Additionally, services is predicted to grow at the fastest CAGR during the forecast period owing to the rising trend toward digitalization in manufacturing processes, increased focus on safeguarding data integrity & cybersecurity. MES service providers specialize in implementing strong security measures to safeguard sensitive information and ensure adherence to industry regulations.
By deployment, on-premise was the highest revenue-grossing segment in the global manufacturing execution system in life sciences market in 2023 owing to the rising trend in the introduction of advanced systems. On-premise solutions provide enhanced control over data security and privacy, mitigating worries regarding sensitive information and intellectual property. Furthermore, life science firms frequently handle extensive volumes of intricate data produced during manufacturing, encompassing essential quality control parameters and batch tracking details. On-premise MES solutions deliver the requisite computing power and storage capability to effectively manage such data-intensive procedures. Additionally, cloud/web-based is predicted to grow at the fastest CAGR during the forecast period owing to the increase in demand for smooth integration with current enterprise resource planning (ERP) systems, laboratory information management systems (LIMS), & other legacy applications, particularly within the life science sector. Leading market players are undertaking initiatives to address this growing need. For instance, in April 2023, GE Digital, a key division of GE Vernova's energy portfolio and a prominent provider of innovative solutions in the Manufacturing Execution System (MES) market, has been recognized by Gartner for the second year in a row as a Leader in the Magic Quadrant for Manufacturing Execution Systems. This acknowledgment is attributed to its Proficy Smart Factory (MES) software solution.
By end-user, pharmaceutical & biotechnology companies was the highest revenue-grossing segment in the global manufacturing execution system in life sciences market in 2023 owing to the increase in partnerships among industry participants and growing introduction of innovative systems. MES solutions empower companies to oversee production lines meticulously, thereby maintaining their competitiveness. Biotechnology firms also find value in MES for efficiently overseeing the intricate processes associated with manufacturing biologics and personalized medications. For instance, in October 2023, Quadrant Knowledge Solutions released the SPARK Matrix analysis report on the worldwide MES - Process & Batch Market. Additionally, medical device companies is predicted to grow at the fastest CAGR during the forecast period. Producing medical devices poses unique obstacles that companies must overcome to remain competitive. This entails striking a careful equilibrium between reducing costs and ensuring regulatory adherence, all while maintaining a steady output of top-notch products.
North America region is anticipated for the highest revenue share during the forecast period owing to the rise in technological progress, widespread implementation of software solutions in life science manufacturing, growing uptake of integrated laboratory automation solutions, and increase in partnerships among industry participants. For instance, in January 2024, CGI Group, a Canadian IT consulting company, revealed a partnership with Korber to utilize its Werum PAS-X MES Suite for serving pharmaceutical clients. This MES suite, designed specifically for the pharmaceutical and biotechnology sectors, is offered as either an on-premise or cloud-based solution. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rise in the number of pharmaceutical companies, the prominence of key market players, uptick in the adoption of MES solutions to digitize production processes & improve operational efficiency, growing demand for high-quality drugs, increasing necessity to ramp up pharmaceutical production, and surge in the introduction of advanced systems. For instance, in February 2023, AVEVA Group Limited, a leading industrial software company, introduced the latest version of its AVEVA Manufacturing Execution System. The objective of this new release is to streamline the implementation of multi-site MES solutions and lower the associated expenses and intricacies. With its most recent iteration, AVEVA MES facilitates quicker and more effective adoption of best practices, potentially resulting in enhanced operational efficiency and sustainability.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Increase in the introduction of advanced manufacturing execution systems in life sciences is predicted to boost the market growth during the forecast period. The integration of Manufacturing Execution System (MES) is becoming increasingly pivotal in the life science sector, contributing to enhancements in efficiency, compliance, and innovation throughout production operations. Industries within life sciences, such as pharmaceuticals and biotechnology, demand a refined strategy for managing manufacturing processes. MES offers comprehensive and data-oriented solutions that play a crucial role in fulfilling and surpassing regulatory standards, mitigating risks, and maintaining product quality. For instance, in January 2022, POMS Corporation introduced new MES Dashboards and Batch Records tailored for drug manufacturers operating in the pharmaceutical, biotechnology, and cell and gene sectors. This unveiling is anticipated to provide notable advantages to manufacturers within these industries.
By solution, software was the highest revenue-grossing segment in the global manufacturing execution system in life sciences market in 2023 owing to the growing focus on ensuring data integrity, traceability, & regulatory adherence within the life sciences sector, rising need for comprehensive visibility throughout the entire manufacturing lifecycle, uptick in research & development initiatives, life sciences companies are increasingly investing in Manufacturing Execution System (MES) solutions that provide seamless data integration and analytics capabilities, and rising collaborations among market participants. For instance, in September 2023, Korber and Endeavor have joined forces to streamline the integration of Werum PAS-X MES with SAP's ERP platform. This collaboration is designed to offer a seamless solution to businesses utilizing both software platforms for their operations. Additionally, services is predicted to grow at the fastest CAGR during the forecast period owing to the rising trend toward digitalization in manufacturing processes, increased focus on safeguarding data integrity & cybersecurity. MES service providers specialize in implementing strong security measures to safeguard sensitive information and ensure adherence to industry regulations.
By deployment, on-premise was the highest revenue-grossing segment in the global manufacturing execution system in life sciences market in 2023 owing to the rising trend in the introduction of advanced systems. On-premise solutions provide enhanced control over data security and privacy, mitigating worries regarding sensitive information and intellectual property. Furthermore, life science firms frequently handle extensive volumes of intricate data produced during manufacturing, encompassing essential quality control parameters and batch tracking details. On-premise MES solutions deliver the requisite computing power and storage capability to effectively manage such data-intensive procedures. Additionally, cloud/web-based is predicted to grow at the fastest CAGR during the forecast period owing to the increase in demand for smooth integration with current enterprise resource planning (ERP) systems, laboratory information management systems (LIMS), & other legacy applications, particularly within the life science sector. Leading market players are undertaking initiatives to address this growing need. For instance, in April 2023, GE Digital, a key division of GE Vernova's energy portfolio and a prominent provider of innovative solutions in the Manufacturing Execution System (MES) market, has been recognized by Gartner for the second year in a row as a Leader in the Magic Quadrant for Manufacturing Execution Systems. This acknowledgment is attributed to its Proficy Smart Factory (MES) software solution.
By end-user, pharmaceutical & biotechnology companies was the highest revenue-grossing segment in the global manufacturing execution system in life sciences market in 2023 owing to the increase in partnerships among industry participants and growing introduction of innovative systems. MES solutions empower companies to oversee production lines meticulously, thereby maintaining their competitiveness. Biotechnology firms also find value in MES for efficiently overseeing the intricate processes associated with manufacturing biologics and personalized medications. For instance, in October 2023, Quadrant Knowledge Solutions released the SPARK Matrix analysis report on the worldwide MES - Process & Batch Market. Additionally, medical device companies is predicted to grow at the fastest CAGR during the forecast period. Producing medical devices poses unique obstacles that companies must overcome to remain competitive. This entails striking a careful equilibrium between reducing costs and ensuring regulatory adherence, all while maintaining a steady output of top-notch products.
North America region is anticipated for the highest revenue share during the forecast period owing to the rise in technological progress, widespread implementation of software solutions in life science manufacturing, growing uptake of integrated laboratory automation solutions, and increase in partnerships among industry participants. For instance, in January 2024, CGI Group, a Canadian IT consulting company, revealed a partnership with Korber to utilize its Werum PAS-X MES Suite for serving pharmaceutical clients. This MES suite, designed specifically for the pharmaceutical and biotechnology sectors, is offered as either an on-premise or cloud-based solution. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rise in the number of pharmaceutical companies, the prominence of key market players, uptick in the adoption of MES solutions to digitize production processes & improve operational efficiency, growing demand for high-quality drugs, increasing necessity to ramp up pharmaceutical production, and surge in the introduction of advanced systems. For instance, in February 2023, AVEVA Group Limited, a leading industrial software company, introduced the latest version of its AVEVA Manufacturing Execution System. The objective of this new release is to streamline the implementation of multi-site MES solutions and lower the associated expenses and intricacies. With its most recent iteration, AVEVA MES facilitates quicker and more effective adoption of best practices, potentially resulting in enhanced operational efficiency and sustainability.
This comprehensive research report focuses on the global and regional market size and forecasts from 2023 to 2034.
Report Scope:
- Base Year: 2023
- Forecast Period: 2024-2034
- Study Coverage
- Market Forecast by Solution, Deployment, and End-user
- Market Forecast for 5 Regions and 17+ Countries
- North America (U.S. and Canada)
- Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
- Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
- Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
- MEA (South Africa, GCC, Rest of MEA)
- Exhaustive Company Profiles of Top 10+ Major Market Players
Segmentation: Manufacturing Execution System In Life Sciences Market Report 2023 - 2034
Manufacturing Execution System In Life Sciences Market Analysis & Forecast by Solution 2023 - 2034 (Revenue USD Bn)
- Services
- Software
Manufacturing Execution System In Life Sciences Market Analysis & Forecast by Deployment 2023 - 2034 (Revenue USD Bn)
- Cloud/Web-Based
- On-Premise
- Hybrid
Manufacturing Execution System In Life Sciences Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Medical Device Companies
- Pharmaceutical and Biotechnology Companies
- Others
- CDMOs
- CROs
Manufacturing Execution System In Life Sciences Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Manufacturing Execution System In Life Sciences Market: Solution Estimates & Trend Analysis
8. Manufacturing Execution System In Life Sciences Market: Deployment Estimates & Trend Analysis
9. Manufacturing Execution System In Life Sciences Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Manufacturing Execution System In Life Sciences Market
12. Europe Global Manufacturing Execution System In Life Sciences Market
13. Asia Pacific Global Manufacturing Execution System In Life Sciences Market
14. Latin America Global Manufacturing Execution System In Life Sciences Market
15. MEA Global Manufacturing Execution System In Life Sciences Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- MasterControl Solutions Inc.
- Emerson Electric Co.
- Körber AG
- Rockwell Automation
- iBase-t
- ABB
- Cognizant
- AVEVA Group Limited
- Siemens AG
- nagarro
